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ABSTRACT 
 
The protein deacetylase sirtuin 1 (SIRT1) is an established regulator of diverse physiological 
processes and one of several promising targets for pharmacologic modulation of ageing and 
longevity. In normal human keratinocytes, SIRT1 has been shown to inhibit proliferation and 
promote differentiation. MicroRNAs (miRNAs), small non-coding RNA molecules that 
negatively regulate gene expression, have been shown to regulate SIRT1 expression in 
several cell types. Using western blotting, we show that miR-9 represses SIRT1 expression in 
the HaCaT human keratinocytes. The attenuation of SIRT1 levels in response to ectopic miR-
9 occurred in a dose-dependent manner. As miR-9 expression is known to be under 
epigenetic control, the effect of the histone deacetylase (HDAC) inhibitor trichostatin A 
(TSA) was examined. Levels of mature miR-9 increased 8-fold following TSA treatment of 
HaCaT keratinocytes. Expression of the primary transcripts from which miR-9 is derived was 
also raised in HaCaT keratinocytes exposed to TSA, with a 7-fold elevation of pri-miR-9-1 
and 4-fold increase of pri-miR-3. In contrast the DNA methyl transferase inhibitor 5-deoxy-
azacytidine (DAC) had little effect on miR-9 or primary miR-9 expression. Together, our 
findings point to a role for chromatin remodelling in regulating miR-9 levels in human 
keratinocytes and in turn modulation of SIRT1 expression by miR-9.  
 
  
INTRODUCTION 
Sirtuins (SIRT1 to 7) are a family of conserved protein deacetylases that regulate gene 
expression in response to the metabolic status of cells. Intracellular levels of nicotinamide 
adenine dinucleotide NAD+ control SIRT1 activity and SIRT1-dependent deacetylation of 
histone lysines allows chromatin remodelling to support the regulation of genes involved in a 
multiple physiological processes [1]. Activation of SIRT1 has been linked to the extension of 
lifespan in multiple animal models and is therefore a promising pharmaceutical target for 
healthy ageing [2].  
 The exposure of the skin to ultraviolet (UV) radiation is associated with photoageing 
and the development of skin cancer [3,4]. Recent insight from mouse studies suggest gene 
dosage determines SIRT1 function in UVB-induced skin cancer, with enhanced 
tumourigenesis following heterozygous deletion but a tumour suppressive effect for 
homozygous deletion SIRT1 [5].  In addition, upregulation of SIRT1 has been shown to 
promote differentiation and shorten the replicative lifespan of cultured keratinocytes [6]. 
Conversely, depletion of SIRT1 inhibited differentiation and enhanced the replicative 
capacity of keratinocytes [6]. However, the mechanisms regulating SIRT1 expression in 
keratinocytes have not been fully established.  
 MicroRNAs (miRNAs) are small (~22 nucleotides) non-coding RNA 
molecules that control gene expression, generally by post-transcriptional downregulation of 
target mRNA at the protein and/or mRNA level [7,8]. A given miRNA can regulate hundreds 
of distinct mRNA transcripts and consequently, changes in miRNA expression can 
significantly influence physiological and pathological processes [9]. Mature miRNAs are 
generated from primary transcripts (pri-miRNAs) which are usually transcribed from 
intergenic or intronic regions of protein-coding genes [10]. The RNAse III enzyme Drosha 
processes the primary transcripts into precursor miRNAs (pre-miRNAs) which are in turn 
cleaved by another RNAse III, Dicer, to produce the mature miRNA [11].  
Increasing evidence points the regulation of SIRT1 by miR-9 in diverse cell types 
[12-14]. In the study presented here, we extend the known cell types in which miR-9 
modulates SIRT1 expression to include HaCaT keratinocytes. Furthermore, we show that 
treatment of HaCaT keratinocytes with the histone deacetylase inhibitor trichostatin A (TSA) 
leads to the upregulation of mature and primary miR-9.   
 
  
MATERIALS AND METHODS 
 
Transient transfection and Western Blotting 
The p-Super-miR-9 and pSuper vectors [15] were kind gifts from Romano Regazzi 
(University of Lausanne, Switzerland). Cells seeded at 3 x 10
5
 cells/well of a six well plate 
were transfected using Lipofectamine Plus reagents (Thermo Fisher, Paisley, UK) according 
to manufacturer’s instructions.  After 48 h, the cells were lysed by replacing the culture 
medium with 250µl urea lysis buffer (0.1 M Tris-Cl pH 6.8, 7 M urea, 4% SDS, protease 
inhibitor cocktail). For western blotting, 20 µl of protein lysate per lane of a 4-12% gradient 
polyacrylamide gel (Expedeon, Harston, UK) was fractionated by electrophoresis, transferred 
to a polyvinylidene fluoride  membrane, and probed using anti-human SIRT1 antibody 
(1:1000; Abcam Cambridge, UK) or β-actin (1:2000; Abcam).  After incubation with 
horseradish peroxidase-conjugated secondary antibody (1:10,000, Abcam), peroxidase-
dependent chemiluminscence was visualized using Pierce reagents (Thermo Scientific, 
Rockford, IL, USA). Densitometry was performed using Image J software and values for 
SIRT1 normalized to the corresponding β-actin values. 
 
RNA isolation and purification  
HaCaT keratinocytes were cultured as previously reported [16]. Cells were treated with 1 μM 
trichostatin A (TSA) or  5-deoxy-azacytidine (DAC), respectively, and harvested 48 h later. 
Cell lysis and total RNA purification was performed using the Ambion miRVANA (Applied 
Biosystems) RNA extraction kit in accordance with the manufacturer’s specifications. Briefly, 
cells were washed 3 times in PBS prior to addition of 600 µl miRVANA lysis buffer 
(Ambion). The lysate was subsequently transferred to a tube containing 60 µl miRNA 
homogenate additive and mixed by vortexing. After a 10 min incubation on ice, 500 µl of 
acid-phenol:chloroform was added to the lysate. The mixture was vortexed for 30 s and 
centrifuged (10,000 x g for 5 min) to separate the organic and aqueous phases. The aqueous 
phase was transferred to a microcentrifuge tube, mixed with 100% ethanol and passed 
through a glass fibre filter by centrifugation (10,000 x g for 15 s). The filter was washed and 
total RNA was recovered with pre-heated (95°C) elution solution.  
  
Quantitative RT-PCR  
Quantitative PCR (qRT-PCR) for miR-9 expression was performed using a TaqMan miRNA 
assay (Applied Biosystems). Briefly, 20 ng of total RNA was reverse transcribed according to 
manufacturer’s instructions using a stem loop primer specific for miR-9 or for the 
endogenous control gene RNU48, respectively. Quadruplicate qPCR mixtures were then 
prepared, each 20 µl reaction comprising 10 µl TaqMan Universal PCR Master Mix II (2x; 
Applied Biosystems), 7.67 µl nuclease free H2O (Sigma Aldrich), 1 µl TaqMan primers (20x) 
for miR-9 or RNU48 quantification, respectively (Applied Biosystems), and 1.33 µl of RT 
product. Thermocycling was performed on an AB 7500 real time PCR system (Applied 
Biosystems) as follows: incubation at 50°C for 2 min, incubation at 95°C for  10 min, then 40 
cycles of 95°C for 15 s and  60°C for 1 min.  
For quantification of pri-miR-9-1 and pri-miR-9-3,  200 ng of total RNA was reverse 
transcribed and target expression assessed using TaqMan pri-miRNA assays (Applied 
Biosystems) for pri-miR-9-1 , pri-miR-9-3 , respectively. Glyceraldehyde 3-phosphate 
dehydrogenase (GAPDH) levels were also determined as an endogenous control. Preparation 
of qPCR mixtures and thermocycling were performed as outlined above.   
Relative gene expression was determined using the comparative cycle threshold (CT)  
method [17]. Values for miR-9 were normalized to those of RNU48; values for pri-miR-9-1 
and primiR-9-3 to GAPDH mRNA levels, respectively.  
RESULTS 
In HaCaT keratinocytes transfected with a miR-9 expression plasmid, a clear dose-dependent 
attenuation of SIRT1 levels was observed as the plasmid doses exceeded 0.25 μg (Fig.1). The 
lowest dose (0.125 μg) of the miR-9 plasmid, however, appeared to potentiate SIRT1 
expression. No dose-dependent depletion of SIRT1 was observed in cells transfected with an 
empty control plasmid.  
 
 
 
Figure 1: miR-9 as a regulator of SIRT1 protein expression in keratinocytes.  The interaction 
of miR-9 with its predicted target site in human SIRT1 3’UTR is depicted (a). HaCaT 
kerationocytes were transfected with increasing amounts (µg) of vector encoding miR-9 or 
pSuper empty vector (b). Relative SIRT1 levels (means ± SEM, n = 3), normalized to -actin, 
are presented below each panel. 
 
 
  
 
 
Figure 2: Regulation of miR-9 expression in HaCaT keratinocytes. Cells were treated with 
the indicated doses of TSA, DAC or vehicle for 48 h. Data shown represents the mean values 
obtained from 3 independent experiments.  
 
 
 
 
 
Given that miR-9 was reported to be silenced epigenetically in cancer cell lines [18], we 
evaluated the effects of the histone deacetylase inhibitor TSA and the DNA methyl 
transferase (DNMT) inhibitor  DAC on miR-9 expression. As shown in Fig, 2a, TSA 
treatment resulted in an 8-fold increase in miR-9 expression after 48 h. To confirm whether 
the elevation of mature miR-9 was associated with upregulation of its primary transcripts, the 
expression of two pri-miR-9 transcripts were also examined. The levels of pri-miR-9-1 and 
pri-miR-9-3 were raised 7-fold and 4-fold, respectively, by TSA treatment (Fig.2b). In 
contrast, exposure to DAC has little effect of the expression of mature or primary miR-9 
(Fig.2c,d). Hence epigenetic silencing of miR-9 in keratinocytes appears to be associated 
with HDAC rather than DNMT activity.    
   
 
  
DISCUSSION  
SIRT1 is a protein deacetylase that has been implicated in the regulation of cellular and 
organismal ageing [9]. Recent work indicates that miR-9 regulates SIRT1 in mouse 
embryonic stem cells [12] and pancreatic -islet cells [13]. In keratinocytes, depletion of 
SIRT1 appears to prolong replicative capacity, indicating that SIRT1 may contribute to the 
regulation of keratinocyte proliferation [6]. In the study presented here, we have shown that 
ectopic expression of miR-9 in human epidermal keratinocytes downregulates SIRT1. Thus 
miR-9 joins several miRNAs, including miR-138, miR-181a and miR-181b, which have been 
shown to regulate SIRT1 expression in human keratinocytes [19].  However, miR-138, miR-
181a and miR-181b were induced during keratinocyte senescence, whereas miR-9 was not 
reported as a senescence-associated miRNA in keratinocytes. Thus the function of the miR-
9:SIRT1 axis in keratinocytes remains to be fully defined. 
 Elevation of global histone acetylation by HDAC inhibition with TSA is known to 
modulate keratinocyte differentiation [20-22]. As we observed TSA-dependent induction of 
miR-9 in HaCaT keratinocytes, chromatin remodelling may contribute to the elevation of 
miR-9 that has been reported in terminally differentiated keratinocytes [23]. In contrast to 
findings from cancer cells [18], we did not observe de-repression of miR-9 following 
treatment of keratinocytes with DAC suggesting diverse epigenetic mechanisms control miR-
9 expression in different cell types. These mechanisms may be augmented by other pathways 
known to contribute to the expression of miR-9, such as Toll-like receptor, IL-1β and  TNF-α 
signalling [24].  
 In conclusion, we have shown in this study that upregulation of miR-9 leads to 
repression of SIRT1 and the histone deacetylase inhibitor TSA elevates miR-9 expression in 
keratinocytes.  
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